EMGO Institute for Health and Care Research Quality of Care Martina Cornel, Professor of community genetics & public health genomics Integrating genomics.

Slides:



Advertisements
Similar presentations
PERSONALIZED MEDICINE: Planning for the Future You, Your Biomarkers and Your Rights.
Advertisements

Genetics and genomics for healthcare © 2014 NHS National Genetics and Genomics Education Centre Why is genetics relevant to.
Case studies: personal genetic profiling and body imaging Professor Nikolas Rose Martin White Professor of Sociology BIOS Centre for the Study of Biomedicine.
Genetic Analysis in Human Disease
Treuman Katz Center for Pediatric Bioethics Conference Newborn Screening: The Future Revolution Beth A. Tarini, MD, MS Assistant Professor Child.
Project Overview NE FTCC Trainers’ Capacity Building Training May 24-25, 2010 at Mohonk Mountain House, New Paltz, NY Training Objectives: – Increase awareness.
Prepare for Personalized Medicine Family Health History – An important first step in risk assessment for genetic diseases and other hereditary health conditions.
Hereditary Factors in Breast Cancer
The Genetics of Breast and Ovarian Cancer Susceptibility Patricia Tonin, PhD Associate Professor Depts. Medicine, Human Genetics & Oncology McGill University.
1 Development of Hereditary Cancer Prevention Measures in Pskov Region Asoc. Prof. Edvīns Miklaševičs, Riga Stradins University 16 November 2011, St.Petersburg,
Issues in Genetic Testing: Real versus Not-so-Real Roberta A Pagon, MD Principal Investigator, GeneTests Professor, Pediatrics University of Washington.
Evolving Nursing Roles for the Future: The Provision of Genetic and Genomic-Based Nursing Care Throughout the Health Care Continuum Dale Halsey Lea, MPH,
Personalized Medicine in the Era of Genomics Wylie Burke MD PhD Department of Medical History and Ethics Center for Genomics and Healthcare Equality University.
EMGO Institute for Health and Care Research Quality of Care Martina Cornel, MD, PhD, professor of Community Genetics & Public Health Genomics PPPC activities.
Introduction to Molecular Epidemiology Jan Dorman, PhD University of Pittsburgh School of Nursing
Purpose: Serves as guide to accelerate research to reduce the prevalence and burden of obesity, so that people can look forward to healthier lives Enhances.
FORCE XRAY PROGRAM Evaluating Reports on Breast Cancer in the Media.
Genomics Alexandra Hayes. Genomics is the study of all the genes in a person, as well as the interactions of those genes with each other and a person’s.
Genetic Analysis in Human Disease. Learning Objectives Describe the differences between a linkage analysis and an association analysis Identify potentially.
The Predictivity Concept Peter Propping Institute of Human Genetics University of Bonn, Germany CDBI Seminar on predictivity, genetic tests and insurance.
Unit 5 – Public Health Chronic Diseases
Chapter 13 Carrier Screening. Introduction Carrier screening involves testing of individuals for heterozygosity for genes that would produce significant.
Muin J. Khoury MD, PhD Office of Public Health Genomics, CDC.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
The Innovative Medicines Initiative A winning case for Joint Technology Initiative Status.
Genetics and genomics for healthcare © 2014 NHS National Genetics and Genomics Education Centre Genetics and Genomics: Alert,
Bringing Genomics Home Your DNA: A Blueprint for Better Health Dr. Brad Popovich Chief Scientific Officer Genome British Columbia March 24, 2015 / Vancouver,
Plenary III: There is No Health Without Mental Health.
Integration of General Practice in Health services Doris Young Professor of General Practice.
Rachel Liao, PhD Coordinator of the Clinical Working Group and the BRCA Challenge demonstration project for the Global Alliance for Genomics and Health.
Private pay, physician ordered genetic testing Developed by Dr. Judith Allanson, Ms. Shawna Morrison and Dr. June Carroll Last updated November 2015.
Understanding Genetic Testing
Pediatric ACOs The Characteristics of Pediatric Populations and Their Impact on ACOs.
BY MARK NEUHENGEN Personal Genome Evaluation and GINA.
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
Ethics in Clinical Genetics and Genomics Key Knowledge Year 4 Medical Ethics and Law Thread Course, The Ethox Centre, University of Oxford.
Jan 2002 EDMA The central role of the Medical Laboratory in a World of Managed Health An EDMA presentation of the benefits of in vitro testing as a basis.
EMGO Institute for Health and Care Research Quality of Care Martina Cornel Professor of Community Genetics & Public Health Genomics Genomics in health.
EMGO Institute for Health and Care Research Quality of Care Martina Cornel Professor of Community Genetics & Public Health Genomics Public Health Gen-ethics.
Genomics and Population Health Challenges for the Public Health Community Dr Ron Zimmern MA, FRCP, FFPHM Director, Public Health Genetics Unit, Cambridge.
Direct-to-Consumer Genetic Testing: Outputs from the EASAC-FEAM Working Group Martina Cornel VU University Medical Center, Amsterdam.
The PRECeDI project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No VU University.
EMGO Institute for Health and Care Research Quality of Care Martina Cornel Professor of Community Genetics & Public Health Genomics Next generation genomics:
Next generation genomics: translation into clinically useful applications in health care Prof.dr. Martina Cornel
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
1 Finding disease genes: A challenge for Medicine, Mathematics and Computer Science Andrew Collins, Professor of Genetic Epidemiology and Bioinformatics.
EMGO Institute for Health and Care Research Quality of Care Martina Cornel, MD, PhD A public health perspective on direct to consumer genetic testing Community.
Patients’ expectations from genomic applications Nick Meade Director of Policy Genetic Alliance UK Local Networks, Workshop One, 7 th October 2014.
Genes in Life is a place to learn about all the ways genetics is a part of your life. On this site you will learn:   How.
Genetics in Medicine in 2013: is a genetic passport reality?
Moiz Bakhiet, MD, PhD, Professor and Chairman
Hereditary Cancer Predisposition: Updates in Genetic Testing
Genetics as a determinant of health: new challenges for epidemiology
Pathways involved in hereditary breast cancer
Detection of heterozygotes
Barriers and facilitating factors for implementation of genetic services Martina Cornel Professor of Community Genetics and Public Health Genomics VU University.
National Healthcare Science Week 2017
Monogenic Disorders Genetic Counselling
Prof.dr. Martina C Cornel
Danijela Radivojevic Laboratory of Medical Genetics
Figure 1: Questions included in questionnaire
What to screen for and when? 18th January 2014 PACITA Lisbon
THE ROLE OF NEXT GENERATION SEQUENCING IN CLINICAL PRACTICE
Integrating Genetics & Genomics Education into Nursing Workforce
DEFINING REGULATIONS AND PERFORMANCE EVALUATION CRITERIA FOR GENETIC TESTS Prof.dr. Martina Cornel Member of EASAC-FEAM Working Group Direct-to-Consumer.
Integrating Genetics & Genomics Education into Nursing Workforce
Chapter 5: Genetics and genomics perspectives in nursing
Who in the room would offer BRCA1/2 testing to this patient Who in the room would offer BRCA1/2 testing to this patient? How might the medical management.
Content and Labeling of Tests Marketed as Clinical “Whole-Exome Sequencing” Perspectives from a cancer genetics clinician and clinical lab director Allen.
Martina Cornel VU University Medical Center, Amsterdam
Presentation transcript:

EMGO Institute for Health and Care Research Quality of Care Martina Cornel, Professor of community genetics & public health genomics Integrating genomics in health care Service development in oncology and cardiology Community Genetics, Dept Clinical Genetics

Public Health Genomics: definition The responsible and effective translation of genome-based knowledge and technologies into public policy and health services for the benefit of population health genome-based knowledge and technologies=GBIT PACITA report p. 88 (and elsewhere)

Learning goals The student can describe the fast scientific developments in genome-based knowledge and technologies The student can discuss what is needed for translation of genomics knowledge into health care

2000: genome sequence published Bill Clinton: We are here to celebrate the completion of the first survey of the entire human genome … With this profound new knowledge, humankind is on the verge of gaining immense, new power to heal. Genome science will have a real impact on all our lives -- and even more, on the lives of our children. It will revolutionize the diagnosis, prevention and treatment of most, if not all, human diseases. Collins FS (Right at photo). Nature 2010 & © AP PHOTO/RON EDMONDS

Result of large scale genomic research Shifting focus: From single gene (Mendelian) conditions –cystic fibrosis, Duchenne muscular dystrophy, Huntington’s disease To common, complex conditions –diabetes, cardiovascular disease, schizophrenia

Gene or environment? Totally Genetic Totally Environmental Struck by lightning Motor vehicle accident Duchenne muscular dystrophy Cystic fibrosis Heart disease Cancer Schizophrenia Diabetes Obesity Asthma Rheumatoid arthritis PKU Alzheimers Fragile X Autism TB Meningococcus Multiple sclerosis

Understanding the cause of disease Genome wide association studies (GWAS) –Common disorders –SNPs that contribute little to the risk Array and sequencing techniques –Rare disorders (rare variants of common disorders) –Panels to analyse several genes at once Information technologies (high throughput) –Faster and cheaper analysis

Extending scope of testing? Will shifting research lead to shifting health care? –From reproductive tests to predictive testing Clinical genetics for infants with MR/MCA, but increasingly oncogenetics & cardiogenetics? –From reproductive decision making to personal risk reduction –From rare monogenic to common complex diseases Monogenic subtypes –From families to large (sections of) healthy populations Screening

Learning goals The student can describe the fast scientific developments in genome-based knowledge and technologies The student can discuss what is needed for translation of genomics knowledge into health care –From bench to bedside –Phases of translation (Khoury) –Stakeholders (Rigter) –Guidelines (PPPC)

Genetics: “bench” or “bedside”? Science and/or health care? On the left: Watson and Crick describe the structure of DNA Above: clinical geneticist explains the consequences to patients contributions-double-helix-quiz.html#lesson oorlichting/Wanneer_erfelijkheidsonderzoek.htm

Translation needed Libraries cannot be built fast enough to keep up with modern scientific output. But moving this knowledge off the shelves and into practice.. requires translation. Lenfant NEJM 2005;349:868

“Lost in translation” in Lenfant 2005 … the last and perhaps most important segment, … taking the findings of clinical investigations and translating them into the practice of medicine at the community level benefits of beta-blockers for patients who were recovering from myocardial infarction 1996 beta-blockers were being prescribed for only 62.5 percent of patients who had had a myocardial infarction

“Lost in translation” in Lenfant 2005 Late 1980s … benefits of cholesterol lowering in patients with coronary heart disease 1999: only half to three quarters of patients who have had a myocardial infarction are even being screened for elevated serum cholesterol levels, much less being prescribed cholesterol-lowering regimens

Phases in translational research The continuum of translation research in human genetics: types of research Khoury M et al. Genet Med. 2007;9:

Framework for translational research T1 : BRCA mutation is associated with breast cancer T2 Determine the positive predictive value of BRCA mutations, develop guidelines for testing T3 What proportion of women from BRCA families are tested? T4 Does BRCA testing contribute to living longer and healthier? –These steps need to be planned, they do not come automatically

How translational is human genomics research?

Premature translation??

Translation Doesn’t happen automatically –Only small percentage of research budget devoted to translation May come premature –Valorisation=making money/value after investment If you feel a change is needed: look for opportunities and other stakeholders involved

People don’t like change We work in a certain structure, culture & practice Dynamics within or outside this constellation may cause instability Opportunity for change! –2005: cardiac arrest young footballplayer in Sweden Sense of urgence, not only for clinical geneticists but also for cardiologists etc. Rigter, J Community Genet (2014) 5:337–347

Learning goals The student can describe the fast scientific developments in genome-based knowledge and technologies The student can discuss what is needed for translation of genomics knowledge into health care –From bench to bedside –Phases of translation (Khoury) –Stakeholders (Rigter) –Guidelines (PPPC)

What is needed for responsible translation? Source: PhD thesis Tessel Rigter Ch 8

We need other stakeholders! A new technique in the laboratory A clinical geneticist can explain the test results Who will inform the patient that the test is available? Who will refer? For many fields (cancer, cardiovascular disease, diabetes) too many patients to counsel in genetic centres Collaboration needed, new division of tasks

What is needed for responsible translation? Sources: PhD thesis Tessel Rigter Ch 1 And Achterbergh et al. Health Policy 2007;83:

Scaling up Changes start at a small scale and need deepening, broadening, and scaling up before a full transition is accomplished and a new constellation (with adapted culture, structure, and/or practice) –Maturity Onset Diabetes of the Young (MODY) testing UK –initiative of a consultant diabetologist, a molecular geneticist, and a diabetes specialist nurse –Network of diabetic nurses

Rogers technology adoption life cycle Source: wikipedia

Hereditary cancer program in Catalonia, Spain Initiated within the Catalan Institute of Oncology by a group of clinicians and geneticists at the Department of Prevention and Cancer Control in 1998 Most referrals come from medical specialists More than 1,000 carriers of highly penetrant cancer predisposing genes have been identified and are under surveillance More than 900 healthy relatives have been withdrawn from intensive surveillance because they had not inherited the pathogenic mutation

What determines success? Clinical need Evidence for clinical validity, clinical utility Perceived need –Stakeholder’s priority and awareness (patients, payers, doctors, etc.) –Public priority and awareness Health economic evaluation –Are the benefits outweighing the costs?

New constellation? The service is paid for by the Catalan health system Nowadays, similar services are available in other regions in Spain (scaling up) without clear national guidance. Little comparable services are offered for other conditions than cancer because it seems hard to convince other disciplines of the importance of cascade screening. In addition, private companies are increasingly offering testing, which could keep patients and/or family members from utilizing the services offered in regular health care.

Learning goals The student can describe the fast scientific developments in genome-based knowledge and technologies The student can discuss what is needed for translation of genomics knowledge into health care –From bench to bedside –Phases of translation (Khoury) –Stakeholders (Rigter) –Guidelines (PPPC)

Developing guidelines: example Stakeholder meeting Circulate draft consensus statement to participants Invite comments from other experts / www Finalize Evaluate results Plan, do, check, act in due time.

PPPC guidelines Genetic testing in common disorders Direct-to-consumer genetic testing Genetic testing in minors Whole genome sequencing in health care Whole genome sequencing for newborn screening

PPPC guidelines Not a ‘law’ But influential (Council of Europe, IVD regulation) Pinpoint relevant issues for policy making in country Provide & clarify argumentation why something is important May help you to contribute to translation!

Conclusion Integrating genomics techniques in health care needs you! Phases in translation –Protocol, training, evaluation Other stakeholders involved Scaling up from small initiatives Use a structured approach